[Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
D000090:Acetoacetates / Q000097:blood; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007773:Lactates / Q000097:blood; D008660:Metabolism / Q000187:drug effects*; D011773:Pyruvates / Q000097:blood; D013565:Sympatholytics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000090:Acetoacetates; D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D007773:Lactates; D011773:Pyruvates; D013565:Sympatholytics; D005990:Glycerol
Wirkung einer neuen Beta-Rezeptoren blockierenden Substanz auf Hämodynamik und Stoffwechsel des Menschen.